Skip to content

Telemedicine Versus Traditional Specialist Consultation for Headache: a Non-inferiority Trial

Patients' Satisfaction With Telemedicine Versus Traditional Specialist Consultation for Headache. An Open-labeled Randomized Non-inferiority Study Among Patients With Headache Referred to a Neurologic Outpatient Clinic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02270177
Acronym
VHS
Enrollment
402
Registered
2014-10-21
Start date
2012-09-30
Completion date
2016-06-30
Last updated
2016-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headaches

Keywords

Headache, Telemedicine, Videoconsultation, Headache-referrals

Brief summary

Headache is a frequent cause of visits to the GPs office, and the investigators have previously shown that this group accounts for about 20 % of patients referred to a general neurologic outpatient clinic. To our knowledge, no previous study has investigated whether headache consultation through telemedicine provides equal health care outcomes compared to regular visit to the neurologist. If that's the case, a modern interactive health care system may give simpler and cheaper services for patients, saving travelling costs and community expenses. It may possibly also lead to reduced waiting lists, earlier diagnosis and treatment. This is an open-labeled randomized non-inferiority trial of headache patients referred to a neurologic clinic in North-Norway. The aim of this study is to determine whether video consultations are non-inferior to regular consultations in diagnosing and treating primary headaches. The null hypothesis is that there is no difference in patient satisfaction between the two groups. The outcome is assessed 3 and 12 months after the neurologic consultation. Participants will be allocated to either a telemedicine consultation or a regular consultation at the neurologic outpatient clinic in the University Hospital of North-Norway, Tromsø. Both groups will undergo a structured and detailed interview to clarify the diagnosis and establish appropriate treatment. To ensure the best possible representation in the population, our goal is to include at least 70% of all the referred patients that meet the criteria for participation. The randomizations are made through a centralized 8-16 phone line to the research-department in Tromsø, at the University Hospital of North-Norway. Both primary and secondary endpoints will be assessed in questionnaires sent three and 12 months after the consultation. In addition, the quality of the physicians' referrals and calculations of cost savings by using telemedicine will be evaluated. The patients' informed consent will always be obtained before data collection. Patients are able to withdraw from the study at any time. Withdrawal will not affect the treatment or follow up. Local research ethics committee (REC) has approved the study.

Detailed description

Epidemiological research shows that over half of Europe's population suffers from headache. Approximately 11% of the population suffers from migraine, over half of the population have tension-type headache, and 4% have chronic daily headaches. There is clear evidence that headaches, and especially migraines, are under- or misdiagnosed. Headache is a frequent cause of visits to the GPs office, and we have previously shown that this group accounts for about 20 % of patients referred to a general neurologic outpatient clinic. To our knowledge, no previous studies have investigated whether headache consultations through telemedicine provides equal health care outcomes compared to regular visits to the neurologist. If that's the case, a modern interactive health care system may give simpler and cheaper services for patients, saving traveling costs and community expenses. It may possibly also lead to reduced waiting lists, earlier diagnosis and treatment. This is an open-label randomized non-inferiority study of headache patients referred to our neurologic outpatient clinic. The aim of this study is to determine if video consultations are non-inferior to regular consultations in diagnosing and treating primary headaches. The null hypothesis is that there is no difference in patient satisfaction between the two groups. The outcome is assessed 3 and 12 months after the neurologic consultation. We will allocate participants to either a telemedicine consultation or a regular consultation at the neurologic outpatient clinic in the University Hospital of North-Norway, Tromsø. Both groups will undergo a structured and detailed interview to clarify the diagnosis and establish appropriate treatment. All diagnoses are given by the most up to date version of The International Classification of Headache Disorders (ICHD). We will strive continuously to include all patients who meet the inclusion and exclusion criteria. To ensure the best possible representation in the population, our goal is to include at least 70% of all the referred patients that meet the criteria for participation in this study. The randomizations are made through a centralized 8-16 phone line to the research-department in Tromsø, at the University Hospital of North-Norway. We will gather the primary and secondary endpoints from the recruited participants by questionnaires sent three and 12 months after the consultation. In addition, we are going to investigate the quality of the physicians' referrals, peoples' use of medications, alternative therapies as well as calculations of cost savings by using telemedicine. The patients' informed consent will always be obtained before data collection. Patients are able to withdraw from the study at any time. Withdrawal will not affect the treatment or follow up. Local research ethics committee (REC) has approved the study.

Interventions

OTHERTelemedicine, videoconsultation

We are investigating the use of videoconsultations (through telemedicine technology) in patients with primary headaches.

Sponsors

University of Tromso
CollaboratorOTHER
University Hospital of North Norway
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Females and males ≥16 and ≤65 years of age * Referred to a neurologist for headache * No red flags (defined) suggestive of a secondary cause? No known underlying causes of headaches (secondary headaches) according to established criteria * Referred for diagnostic clarification and / or treatment * Waiting time ≤ 4 months from the date of the referral * speaking Norwegian language

Exclusion criteria

* Age \<16 years or \> 65 years of age * Known underlying cause of the headache or the presence of red flags suggestive of secondary headaches. * Examined by a neurologist for headaches in a period of 2 years before referral * Waited longer than 4 months from the date of referral * Non-Norwegian speaker

Design outcomes

Primary

MeasureTime frameDescription
Number of satisfied participantschange from baseline at 3 months and 12 monthsAre you satisfied with the consultation? Yes/No

Secondary

MeasureTime frameDescription
HIT-6Changes from baseline in HIT 6 at 3 months and 12 monthsHeadache impact test
Job situation/occupationchanges from baseline in job situation at 3 months and 12 monthsJob situation/occupation
numbers of consultations during follow upnumbers of consultations from baseline and after 12 monthsnumbers of GP-consultations, hospital consultations and admissions
number of pain killers, triptans and other medications for headacheat baseline, after 3 months and after 12 monthsnumber of medications for headache
headache diagnosisat baseline, after 3 months and 12 monthsHeadache diagnosis after IHS criteria
VAS satisfaction rating scale12 monthsVisual analog satisfaction scale 0-10, where 0 = least satisfied and 10 = most satisfied
VAS pain scalechanges from baseline in VAS at 3 months and 12 monthsHeadache measured by a visual analog scale 0-10, 0= no pain, 10=worst pain

Other

MeasureTime frameDescription
Number of headache days and headacheschange in number of headaches from baseline, at 3 months and 12 monthsChange in number of headache days per month and number of headahces per month
Change in headache featureChange in headache features from baseline, after 3 months and 12 monthsIs the headahce bether, worse or the same. Is the headahce more intens, less intens or unchanged.
Estimation of travelling distances to the neurologic outpatient clinictravelling distance in kilometers for the neurologic consultation (telemedicine versus regular consultation) and the average travelling distance to the GP during the consecutive 11 monthstravelling distances in kilometers
Expenses saved by using telemedicineExpenses (travelling, lost income and days absent from work) for the neurologic consultation and the average expenses for GP-consultations during the consecutive 11 monthsEvaluation of the expenses associated with telemedicine compared to regular consultations (travelling expensis, lost earnings, days away from work,

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026